Hemab Therapeutics Holdings, Inc. COAG 深 滬
交易中 09-08 11:37:07 美东时间
44.705
+0.295
+0.66%
華盛通- 最 高45.49
- 今 開44.03
- 成交量 8.14万股
- 最 低 43.15
- 昨 收 44.41
- 總市值 20.88亿
- 52周最高 55.42
- 市盈率 靜 --
- 換手率 0.17%
- 52周最低 23.0001
- 委 比 93.75%
- 總股本 4671.21万
- 歷史最高 55.42
- 量 比 0.80
- 振 幅 5.27%
- 歷史最低 23.0001
- 每 手 1
- 風險率 10.55%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Why Webuy Global Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving Premarket
Shares of Webuy Global Ltd (NASDAQ:WBUY) rose sharply in pre-market trading. Webuy reported record preliminary unaudited travel bookings of around $4.76 million during the three-day NATAS Fair in Aug. 2026, representing around 42% surge from the more than US$3.34 million figure announced during the ...
08-31 16:53
The Galien Foundation Announces 2026 Prix Galien USA Nominees for "Best Digital Health Solution," "Best Medical Technology," "Incubators, Accelerators and Equity," and "Best Startup"
Celebrating 20 Years of Honoring the Digital Breakthroughs, Pioneering Startups, and Ecosystems Driving the Future of Healthcare NEW YORK, Aug. 13, 2026 /PRNewswire/ -- The Galien Foundation...
08-13 21:00
美股大行评级 | 业绩大超预期！ CoreWeave、超微电脑、Lumentum绩后获多家大行上调目标价
今日重点评级关注：Canaccord Genuity：维持Sagimet Biosciences"买入"评级，目标价从49美元升至56美元；韦德布什：维持Zura Bio"跑赢大市"评级，目标价从15美元升至22美元
08-13 11:44
美股大行评级 | 潜在涨幅207.38%！Truist Securities上调AbCellera Biologics目标价至30美元，维持"买入"评级
今日重点评级关注：Truist Securities：维持AbCellera Biologics"买入"评级，目标价从12美元升至30美元；Stifel：维持Proficient Auto Logistics"买入"评级，目标价从9美元升至12美元
08-12 08:45
HC Wainwright & Co. Maintains Buy on Hemab Therapeutics Hldgs, Raises Price Target to $60
HC Wainwright & Co. analyst Emily Bodnar maintains Hemab Therapeutics Hldgs (NASDAQ:COAG) with a Buy and raises the price target from $52 to $60.
08-12 00:14
Hemab Therapeutics Hldgs Q2 EPS $(0.80) Misses $(0.52) Estimate
Hemab Therapeutics Hldgs (NASDAQ:COAG) reported quarterly losses of $(0.80) per share which missed the analyst consensus estimate of $(0.52) by 53.85 percent. This is a 93.8 percent increase over losses of $(12.91) per share from the same period last year.
08-11 19:07
美股周涨跌榜 | 迷幻药企业ATAI劲升近40%！获礼来38亿美元收购；PayPal升22%
迷幻药企业ATAI劲升近40%！获礼来38亿美元收购；PayPal升22%，拟获Stripe斥资530亿美元收购；AI交易集体熄火，费城半导体指数跌入熊市，闪迪重挫29%>>
07-18 10:30
美股大行评级 | 花旗上调苹果、西部数据、希捷科技、超微电脑等目标价；高盛上调蔚来"买入"评级，目标价7美元
今日重点评级关注：HC Wainwright & Co.：维持艾吉纳斯"买入"评级，目标价从23美元升至30美元；富国银行：上调Q32 Bio评级至"超配"，目标价66美元
07-14 11:36
Hemab Advances Bleeding Disorder Pipeline
Hemab Therapeutics Inc. (NASDAQ:COAG) on Sunday presented new clinical data for its lead candidate HMB-002 in Von Willebrand disease (VWD) and introduced HMB-003, a new program targeting heavy menstrual bleeding, at the International Society on Thrombosis and Hemostasis (ISTH) 2026 Congress. The com...
07-14 01:47
HC Wainwright & Co. Maintains Buy on Hemab Therapeutics Hldgs, Raises Price Target to $52
HC Wainwright & Co. analyst Emily Bodnar maintains Hemab Therapeutics Hldgs (NASDAQ:COAG) with a Buy and raises the price target from $40 to $52.
07-13 18:05
